
Surgical Innovations Group PLC
LSE:SUN

Net Margin
Surgical Innovations Group PLC
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | Company | Market Cap |
Net Margin |
||
---|---|---|---|---|---|
UK |
![]() |
Surgical Innovations Group PLC
LSE:SUN
|
6.5m GBP |
-16%
|
|
US |
![]() |
Abbott Laboratories
NYSE:ABT
|
222.7B USD |
32%
|
|
US |
![]() |
Intuitive Surgical Inc
NASDAQ:ISRG
|
178.1B USD |
29%
|
|
US |
![]() |
Boston Scientific Corp
NYSE:BSX
|
157.5B USD |
14%
|
|
US |
![]() |
Stryker Corp
NYSE:SYK
|
153.1B USD |
12%
|
|
IE |
![]() |
Medtronic PLC
NYSE:MDT
|
118.5B USD |
14%
|
|
DE |
![]() |
Siemens Healthineers AG
XETRA:SHL
|
54.4B EUR |
9%
|
|
US |
![]() |
Becton Dickinson and Co
NYSE:BDX
|
52.3B USD |
7%
|
|
US |
![]() |
Edwards Lifesciences Corp
NYSE:EW
|
47.2B USD |
73%
|
|
US |
![]() |
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.3B USD |
23%
|
|
US |
![]() |
Resmed Inc
NYSE:RMD
|
40.8B USD |
26%
|
Surgical Innovations Group PLC
Glance View
Surgical Innovations Group Plc is a holding company, which engages in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and industrial markets. The Group sells branded products through its Elemental Healthcare Ltd. (Distribution) and independent healthcare distributors across the world and own label products through original equipment manufacturer (OEM) relationships. The firm operates through three segments: SI Brand, OEM and Distribution. The SI Brand segment is engaged in the research, development, manufacture and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. Its Distribution segment is engaged in the distribution of specialist medical products sold through its Elemental Healthcare Ltd.

See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on Surgical Innovations Group PLC's most recent financial statements, the company has Net Margin of -16.3%.